Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2707) 2707
Book Chapter (20) 20
Newsletter (18) 18
Newspaper Article (8) 8
Magazine Article (6) 6
Dissertation (2) 2
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (1621) 1621
humans (1575) 1575
life sciences & biomedicine (1572) 1572
male (1396) 1396
allopurinol (1273) 1273
animals (911) 911
female (829) 829
allopurinol - administration & dosage (826) 826
allopurinol - therapeutic use (822) 822
biological and medical sciences (722) 722
medical sciences (683) 683
allopurinol - pharmacology (655) 655
middle aged (579) 579
adult (536) 536
aged (449) 449
rats (436) 436
gout (426) 426
uric acid - blood (397) 397
pharmacology. drug treatments (355) 355
gout - drug therapy (353) 353
abridged index medicus (337) 337
allopurinol - adverse effects (335) 335
uric acid (333) 333
pharmacology & pharmacy (322) 322
xanthine oxidase - antagonists & inhibitors (281) 281
care and treatment (267) 267
treatment outcome (243) 243
time factors (230) 230
drug therapy, combination (222) 222
gout suppressants - therapeutic use (221) 221
rheumatology (199) 199
surgery (189) 189
risk factors (188) 188
dose-response relationship, drug (184) 184
xanthine oxidase (174) 174
hyperuricemia (173) 173
dosage and administration (168) 168
drug therapy (162) 162
cardiovascular system & cardiology (155) 155
gout suppressants - administration & dosage (154) 154
mice (154) 154
hyperuricemia - drug therapy (151) 151
rats, wistar (147) 147
febuxostat (146) 146
research (143) 143
xanthine oxidase - metabolism (143) 143
adolescent (142) 142
administration, oral (141) 141
aged, 80 and over (139) 139
oxidative stress (136) 136
gout suppressants - adverse effects (134) 134
free radicals (132) 132
analysis (131) 131
general & internal medicine (129) 129
enzyme inhibitors - pharmacology (127) 127
medicine, general & internal (122) 122
cardiac & cardiovascular systems (121) 121
medicine & public health (121) 121
disease models, animal (120) 120
organ preservation solutions (120) 120
uric acid - metabolism (117) 117
xanthine (115) 115
glutathione (113) 113
adenosine (112) 112
oxidases (109) 109
rats, sprague-dawley (109) 109
rheumatism (109) 109
dogs (108) 108
transplantation (106) 106
patients (105) 105
research article (105) 105
child (104) 104
health aspects (104) 104
retrospective studies (103) 103
double-blind method (102) 102
insulin (100) 100
drug interactions (96) 96
gout - blood (96) 96
liver - drug effects (95) 95
raffinose (95) 95
complications and side effects (94) 94
gastroenterology & hepatology (94) 94
uric acid - urine (94) 94
immunology (93) 93
oncology (93) 93
enzyme inhibitors - therapeutic use (92) 92
rats, inbred strains (91) 91
urology & nephrology (89) 89
drug administration schedule (84) 84
follow-up studies (84) 84
medicine (84) 84
clinical trials (83) 83
studies (81) 81
hypertension (80) 80
internal medicine (80) 80
biochemistry & molecular biology (79) 79
drug dosages (79) 79
liver (79) 79
reperfusion injury - prevention & control (79) 79
physiology (77) 77
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2564) 2564
German (84) 84
Japanese (68) 68
French (24) 24
Spanish (20) 20
Russian (15) 15
Italian (11) 11
Chinese (10) 10
Danish (9) 9
Portuguese (9) 9
Polish (7) 7
Hungarian (6) 6
Korean (5) 5
Hebrew (2) 2
Serbian (2) 2
Swedish (2) 2
Turkish (2) 2
Czech (1) 1
Persian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia
by Getachew, Henok and Tadesse, Yewondwossen and Shibeshi, Workineh
BMC nephrology, ISSN 1471-2369, 10/2015, Volume 16, Issue 1, pp. 158 - 158
Prospective | Dose adjustment | Renal impairment | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Prospective Studies | Spironolactone - administration & dosage | Humans | Middle Aged | Fluconazole - administration & dosage | Antihypertensive Agents - administration & dosage | Male | Young Adult | Drug Dosage Calculations | Aged, 80 and over | Adult | Female | Cimetidine - administration & dosage | Enalapril - administration & dosage | Pharmaceutical Preparations - administration & dosage | Medication Errors | Severity of Illness Index | Diuretics - administration & dosage | Vancomycin - administration & dosage | Cross-Sectional Studies | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Hospitalization | Acute Kidney Injury - physiopathology | Anti-Arrhythmia Agents - administration & dosage | Creatinine - urine | Renal Insufficiency, Chronic - physiopathology | Anti-Ulcer Agents - administration & dosage | Gout Suppressants - administration & dosage | Drug Prescriptions - statistics & numerical data | Allopurinol - administration & dosage | Digoxin - administration & dosage | Adolescent | Ceftazidime - administration & dosage | Creatinine - blood | Aged | Anti-Bacterial Agents - administration & dosage | Antifungal Agents - administration & dosage | Ethiopia | Drugs | Prescribing | Medical research | Hospital patients | Prescription writing | Analysis | Medicine, Experimental | Medical care | Quality management | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Allopurinol Administration for the Prevention of Contrast-Induced Nephropathy: A Network Meta-analysis With Trial Sequential Analysis
by Bellos, Ioannis and Iliopoulos, Dimitrios C and Perrea, Despina N
Journal of cardiovascular pharmacology, ISSN 0160-2446, 05/2019, Volume 73, Issue 5, pp. 307 - 315
Cardiac & Cardiovascular Systems | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Fluid Therapy | Kidney - drug effects | Humans | Risk Factors | Treatment Outcome | Gout Suppressants - adverse effects | Acute Kidney Injury - physiopathology | Acute Kidney Injury - prevention & control | Incidence | Randomized Controlled Trials as Topic | Gout Suppressants - therapeutic use | Allopurinol - therapeutic use | Contrast Media - adverse effects | Allopurinol - adverse effects | Acute Kidney Injury - chemically induced | Acute Kidney Injury - epidemiology | Network Meta-Analysis | Kidney - physiopathology | Cytoprotection | Complications and side effects | Dosage and administration | Kidney diseases | Angiography | Allopurinol | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Febuxostat administration for the prevention of tumour lysis syndrome: A meta‐analysis
by Bellos, Ioannis and Kontzoglou, Konstantinos and Psyrri, Amanda and Pergialiotis, Vasilios
Journal of clinical pharmacy and therapeutics, ISSN 0269-4727, 08/2019, Volume 44, Issue 4, pp. 525 - 533
tumour lysis syndrome | hyperuricemia | febuxostat | meta‐analysis | allopurinol | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Febuxostat - adverse effects | Gout Suppressants - administration & dosage | Tumor Lysis Syndrome - prevention & control | Animals | Allopurinol - administration & dosage | Humans | Allopurinol - adverse effects | Tumor Lysis Syndrome - blood | Uric Acid - blood | Gout Suppressants - adverse effects | Febuxostat - administration & dosage | Prevention | Medicine, Experimental | Medical research | Uric acid | Analysis | Tumors | Scientific papers | Cytolysis | Acids | Allopurinol | Lysis | Clinical trials | Search engines | Safety | Incidence | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text GC–MS analysis of blood for the metabonomic investigation of the effects of physical exercise and allopurinol administration on rats
by Pechlivanis, Alexandros and Chatziioannou, Anastasia Chrysovalantou and Veskoukis, Aristidis S and Kouretas, Dimitrios and Mougios, Vassilis and Theodoridis, Georgios A
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, ISSN 1570-0232, 09/2014, Volume 966, pp. 127 - 131
Physical exercise | Metabolomics | GC–MS | Allopurinol | Metabonomics | GC-MS | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Biochemical Research Methods | Chemistry, Analytical | Science & Technology | Gas Chromatography-Mass Spectrometry - methods | Reproducibility of Results | Rats, Wistar | Metabolome - physiology | Rats | Male | Biomarkers - blood | Physical Conditioning, Animal - physiology | Metabolomics - methods | Animals | Allopurinol - administration & dosage | Analysis of Variance | Metabolome - drug effects | Allopurinol - pharmacology | Sports sciences | Exercise | Metabolites | Investigations | Oxidases | Care and treatment | Oxalic acid | Gout | Amino acids | Oxalates | Index Medicus | Separation | Free radicals | Statistical analysis | Inhibitors | Samples | Exhaustion | Statistical methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Maternal allopurinol administration during suspected fetal hypoxia: a novel neuroprotective intervention? A multicentre randomised placebo controlled trial
by Kaandorp, Joepe J and Benders, Manon J N L and Schuit, Ewoud and Rademaker, Carin M A and Oudijk, Martijn A and Porath, Martina M and Oetomo, Sidarto Bambang and Wouters, Maurice G A J and van Elburg, Ruurd M and Franssen, Maureen T M and Bos, Arie F and de Haan, Timo R and Boon, Janine and de Boer, Inge P and Rijnders, Robbert J P and Jacobs, Corrie J W F M and Scheepers, Liesbeth H C J and Gavilanes, Danilo A W and Bloemenkamp, Kitty W M and Rijken, Monique and van Meir, Claudia A and von Lindern, Jeannette S and Huisjes, Anjoke J M and Bakker, Saskia C M J E R and Mol, Ben W J and Visser, Gerard H A and Van Bel, Frank and Derks, Jan B
Archives of disease in childhood. Fetal and neonatal edition, ISSN 1359-2998, 05/2015, Volume 100, Issue 3, pp. F216 - F223
Life Sciences & Biomedicine | Pediatrics | Science & Technology | Dinoprost - blood | Double-Blind Method | Maternal-Fetal Exchange | Humans | Male | Aldehydes - blood | Enzyme Inhibitors - therapeutic use | S100 Calcium Binding Protein beta Subunit - blood | Pregnancy | Allopurinol - therapeutic use | Oxypurinol - blood | Ketones - blood | Fetal Blood - chemistry | Fetal Hypoxia - drug therapy | Adult | Female | Dinoprost - analogs & derivatives | Allopurinol - blood | Xanthine Oxidase - antagonists & inhibitors | Complications and side effects | Care and treatment | Usage | Brain-damaged children | Allopurinol | Clinical trials | Dosage and administration | Fetal anoxia | Studies | Free radicals | Brain research | Womens health | Rodents | Fetuses | Brain damage | Hypoxia | Umbilical cord | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol
by Perez-Ruiz, Fernando and Sundy, John S and Miner, Jeffrey N and Cravets, Matthew and Storgard, Chris and RDEA594-203 Study Grp and RDEA594-203 Study Group
Annals of the rheumatic diseases, ISSN 0003-4967, 06/2016, Volume 75, Issue 6, pp. 1074 - 1080
Life Sciences & Biomedicine | Rheumatology | Science & Technology | Triazoles - administration & dosage | Double-Blind Method | Humans | Middle Aged | Gout - drug therapy | Male | Treatment Outcome | Gout Suppressants - administration & dosage | Thioglycolates - administration & dosage | Allopurinol - administration & dosage | Adult | Female | Drug Therapy, Combination | Clinical trials | Care and treatment | Usage | Dosage and administration | Allopurinol | Gout | Index Medicus | Clinical and Epidemiological Research | Inflammation | Treatment | Pharmacokinetics | 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text pH-Dependent 5-Aminosalicylates Releasing Preparations Do Not Affect Thiopurine Metabolism
by Takahashi, Kenichiro and Bamba, Shigeki and Morita, Yasuhiro and Nishida, Atsushi and Kawahara, Masahiro and Inatomi, Osamu and Sugimoto, Mitsushige and Sasaki, Masaya and Andoh, Akira
Digestion, ISSN 0012-2823, 11/2019, Volume 100, Issue 4, pp. 238 - 246
Original Paper | Mesalazine | Crohn's disease | Ulcerative colitis | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | Immunosuppressive Agents - pharmacokinetics | Middle Aged | Male | Guanine Nucleotides - pharmacokinetics | Inflammatory Bowel Diseases - metabolism | Young Adult | Thionucleotides - administration & dosage | Drug Interactions | Time Factors | Guanine Nucleotides - administration & dosage | Adult | Female | Retrospective Studies | Mercaptopurine - analogs & derivatives | Immunosuppressive Agents - administration & dosage | Mercaptopurine - pharmacokinetics | Mesalamine - administration & dosage | Inflammatory Bowel Diseases - drug therapy | Administration, Oral | Mesalamine - pharmacokinetics | Mercaptopurine - administration & dosage | Inflammatory Bowel Diseases - blood | Allopurinol - administration & dosage | Adolescent | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Drug Liberation | Thionucleotides - pharmacokinetics | Aged | Allopurinol - pharmacokinetics | Hydrogen-Ion Concentration | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Exacerbation of allopurinol‐induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: A case report
by Taghvaye Masoumi, H and Hadjibabaie, M and Zarif‐Yeganeh, M and Arasteh, O
Journal of clinical pharmacy and therapeutics, ISSN 0269-4727, 10/2017, Volume 42, Issue 5, pp. 642 - 645
teicoplanin | drug reaction with eosinophilia and systemic symptoms | allopurinol | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Vidarabine - analogs & derivatives | Gout Suppressants - adverse effects | Cytarabine - administration & dosage | Gout Suppressants - administration & dosage | Teicoplanin - adverse effects | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Teicoplanin - administration & dosage | Allopurinol - administration & dosage | Allopurinol - adverse effects | Female | Anti-Bacterial Agents - adverse effects | Vidarabine - administration & dosage | Drug Hypersensitivity Syndrome - etiology | Anti-Bacterial Agents - administration & dosage | Granulocyte Colony-Stimulating Factor - administration & dosage | Drugs | Complications and side effects | Chemotherapy | Leukemia | Allopurinol | Dosage and administration | Eosinophilia | Cancer | Liver | Exanthema | Prophylaxis | Pruritus | Drug development | Hydrocortisone | Cytarabine | Dyspnea | Granulocyte colony-stimulating factor | Colony-stimulating factor | Drug dosages | Enzymes | Limbs | Edema | Alanine | Acute lymphatic leukemia | Hypersensitivity | Abnormalities | Case reports | Fever | Side effects | Fludarabine | Lysis | Alanine transaminase | Respiration | Erythema | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout
by Reinders, M K and Haagsma, C and Jansen, T L Th A and van Roon, E N and Delsing, J and van de Laar, M A F J and Brouwers, J R B J
Annals of the rheumatic diseases, ISSN 0003-4967, 06/2009, Volume 68, Issue 6, pp. 892 - 897
KIDNEY-DISEASE | URATE | ATTACKS | MANAGEMENT | HYPERURICEMIA | THERAPY | PREVENTION | OSTEOARTHRITIS | ARTHRITIS | URIC-ACID | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Miscellaneous. Osteoarticular involvement in other diseases | Purines and pyrimidines (gout, hyperuricemia...) | Other metabolic disorders | Diseases of the osteoarticular system | Inflammatory joint diseases | Biological and medical sciences | Metabolic diseases | Medical sciences | Confidence Intervals | Prospective Studies | Humans | Middle Aged | Gout - drug therapy | Male | Dose-Response Relationship, Drug | Oxypurinol - blood | Drug-Related Side Effects and Adverse Reactions | Female | Uric Acid - blood | Gout - blood | Drug Administration Schedule | Uricosuric Agents - administration & dosage | Treatment Outcome | Gout Suppressants - adverse effects | Benzbromarone - administration & dosage | Gout Suppressants - administration & dosage | Gout Suppressants - therapeutic use | Allopurinol - therapeutic use | Benzbromarone - therapeutic use | Allopurinol - administration & dosage | Benzbromarone - adverse effects | Allopurinol - adverse effects | Uricosuric Agents - adverse effects | Aged | Patient Compliance | Uricosuric Agents - therapeutic use | Usage | Gout | Patient outcomes | Allopurinol | Dosage and administration | Drug therapy | Health aspects | Studies | Clinical medicine | Drug dosages | Success | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
by Keenan, Robert T., MD, MPH and O'Brien, William R., MD and Lee, Kristen H., MD and Crittenden, Daria B., MD and Fisher, Mark C., MD, MPH and Goldfarb, David S., MD and Krasnokutsky, Svetlana, MD, MS and Oh, Cheongeun, PhD and Pillinger, Michael H., MD
The American journal of medicine, ISSN 0002-9343, 2011, Volume 124, Issue 2, pp. 155 - 163
Internal Medicine | Treatment | Drug contraindication | Comorbidity | Gout | Quality of care | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | General aspects | Diseases of the osteoarticular system | Inflammatory joint diseases | Biological and medical sciences | Medical sciences | Epidemiology | Severity of Illness Index | Glucocorticoids - administration & dosage | Prevalence | Humans | Middle Aged | Uricosuric Agents - administration & dosage | Gout - drug therapy | Probenecid - administration & dosage | Colchicine - administration & dosage | Male | Gastroesophageal Reflux - epidemiology | Drug Prescriptions - standards | Contraindications | Gout Suppressants - administration & dosage | Renal Insufficiency, Chronic - epidemiology | Allopurinol - administration & dosage | Gout - epidemiology | Hepatitis, Chronic - epidemiology | Diabetes Mellitus - epidemiology | Aged, 80 and over | Female | Aged | Hypertension - epidemiology | Medical research | Rheumatism | Pharmacology | Drug therapy | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights